1. 1 Bi o medical Designs Provides Smart Catheter Solutions January 2012

2. 2 Clinician’s Pain ProblemSolution Incorrect Catheter Placement Rapid and Sure Placement Catheter Migration Location Monitoring No Preliminary DiagnosticsIntegrated Diagnostic MicroSensors BI O MEDICAL DESIGNS

3. 3 Societal Impact and Consequences of Endotracheal Tubes (ETT) and Nasogastric Tubes (NGT) Misplacement and Lack of Monitoring   ETT- 350,000 annual cases of Ventilator Acquired Pneumonia - Cost $3.0 billion.   NGT - 65,000 annual cases of aspirated pneumonia (following abdominal surgery) - Cost $2.0 billion. BI O MEDICAL DESIGNS

4. 4 Societal Impact and Consequences of ETT and NGT Misplacement and Lack of Monitoring - II   >$100 million annual Lawsuits from misplaced or migrating NGT or ETT that lead to either severe injury or death.   The “gold standard” x-ray to confirm NGT placement - That provides only a “ momentary snap shot” - Cost $62.5 million annually.   ETT x-ray “momentary snap shots” - Annual cost $600 million.   Misinterpretation of x-rays taken is another issue with an unknown cost. BI O MEDICAL DESIGNS

5. 5 The Solution: SmartCath Nasogastric tubes ( NGT) Endotracheal tubes (ETT) BI O MEDICAL DESIGNS

6. 6 NG-ET Optimizer Technology Base unit with Display Encapsulated RFID & Sensors for NGT or ETT tip A Reader to send key health parameters to the Base unit for interpretation and display. BI O MEDICAL DESIGNS

7. 7 SmartCath System Replaces multiple ineffective position techniques, provides ongoing monitoring and display of key health parameters

8. 8 Biomedical Designs Developmental Timelines Conforming to FDA and Industry Requirements Stages of Development Process: Catheter development ElectronicUnitDevelopment Regulatory submission Proof of concept for Industry Deliverable Sensorized Nasogastric, Endotracheal Catheters Catheter integration development FDA regulatory process during development cycle Design production of catheters and systems/ conduct clinical testing Cost$450k$950k$30$1.9 Timing 9 months (in conjunction with electronic system development) 9 months ( in conjunction with catheter development) Conducted during catheter system development 12 months Provider Bit- MedTech Bit-MedTechAlquest Hospital Surgical units and ICU’s BI O MEDICAL DESIGNS

9. 9 Projected NGT Sales BI O MEDICAL DESIGNS

10. 10 Projected ETT Sales BI O MEDICAL DESIGNS

11. 11 Biomedical Designs Key Personnel  Suzanne Biddiscombe, B.A., M.A., CEO – 20 years in sales and marketing. Responsible for the day to day operations of Biomedical Designs, specifically research, business plan development, marketing and sales. David Decker – CFO; President of Personnel Communications. A highly successful entrepreneur in multiple fields. Provided capital to develop the two prototype base units that comprise the SmartCath System.David Decker – CFO; President of Personnel Communications. A highly successful entrepreneur in multiple fields. Provided capital to develop the two prototype base units that comprise the SmartCath System. Dr. Jimmie Spraker, Jr. CSO; PhD, EE – Co-inventor of technology. 25 years experience in hardware and software development and engineering. Jimmie’s entire 30 year career has been dedicated to the advancement of the biotechnology field.Dr. Jimmie Spraker, Jr. CSO; PhD, EE – Co-inventor of technology. 25 years experience in hardware and software development and engineering. Jimmie’s entire 30 year career has been dedicated to the advancement of the biotechnology field. BI O MEDICAL DESIGNS

12. 12 Biomedical Designs Key Personnel  Kim Chaffee- B.S. E.M.T – Director of Smith’s Medical North American Division of Anesthesiology. Kim has been with Smith’s Medical for 15 years and has extensive knowledge of the respiratory care arena within the hospital environment. She oversees Smith’s Respiratory marketing team within the United States.  C. William King – BSEE, MBA, CEO and President of Essential Research, Inc., A high tech entrepreneur with experience in four startups since 1998. Bringing more than 50 new products to the market with a cumulative value >$250 million, including >12 new products requiring 510 k approval.  Patty Kelly – A registered nurse with over 25 years of experience working in Hospital ICU’s. Consulted during the development of the two prototype units.  Dr. Sandra Perez-Spraker, MD, RN. Worked for over 10 years in ICU’s and ER’s. Consulted during the development of two prototype units. BI O MEDICAL DESIGNS

13. 13 Intellectual Property Status All Patent Filings are Pending: Filing Date  Nasogastric Placement and Monitoring System May 2007  Medical Device Placement and Monitoring Device Utilizing Radio Frequency Identification July 2009 BI O MEDICAL DESIGNS

14. 14 Capital Required Capital Required  Biomedical Designs, LLC has raised and invested $500K to date  Clinical Testing and FDA approval are the next significant inflection points  Amount: $4,500,000 to complete  Structure: Percentage of return based upon Investment  Timing: Spring 2012 BI O MEDICAL DESIGNS

15. 15 Exit Strategy Biomedical Designs, LLC is a catheter development oriented company, with these key objectives:  Be a research oriented company advancing numerous proprietary catheter technologies to engage designed electronics.  Within 24 months complete technology, testing and FDA approval.  Within 30 months return the principal of investments plus percentage on sale of technology.  Create liquidity through sale of completed technology to tube manufacturer, medical device manufacturer, or recognized industry leader in respiratory care or equivalent. BI O MEDICAL DESIGNS

16. 16 Contact Information Suzanne M. Biddiscombe, CEO Phone: 678-794-5657 Phone: 678-794-5657 e-mail: Suzanne4sure@yahoo.com e-mail: Suzanne4sure@yahoo.comSuzanne4sure@yahoo.com website: www.biomedicaldesigns.com website: www.biomedicaldesigns.com Video Demonstration available BI O MEDICAL DESIGNS